Zuora (ZUO) Competitors

Enfusion (NYSE:ENFN) and Zuora (NYSE:ZUO) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

Does the MarketBeat Community favor ENFN or ZUO?

Zuora received 207 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 63.99% of users gave Zuora an outperform vote while only 17.02% of users gave Enfusion an outperform vote.

Company	Underperform	Outperform
Enfusion	Outperform Votes 8 17.02%	Underperform Votes 39 82.98%
Zuora	Outperform Votes 215 63.99%	Underperform Votes 121 36.01%

Which has more risk & volatility, ENFN or ZUO?

Enfusion has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, Zuora has a beta of 1.9, indicating that its stock price is 90% more volatile than the S&P 500.

Do analysts rate ENFN or ZUO?

Enfusion presently has a consensus target price of $9.33, suggesting a potential upside of 1.23%. Zuora has a consensus target price of $12.00, suggesting a potential upside of 28.34%. Given Enfusion's stronger consensus rating and higher probable upside, analysts plainly believe Zuora is more favorable than Enfusion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enfusion	3 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Zuora	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Does the media refer more to ENFN or ZUO?

In the previous week, Zuora had 17 more articles in the media than Enfusion. MarketBeat recorded 22 mentions for Zuora and 5 mentions for Enfusion. Zuora's average media sentiment score of 0.80 beat Enfusion's score of 0.29 indicating that Enfusion is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enfusion	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zuora	7 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

Which has better valuation & earnings, ENFN or ZUO?

Enfusion has higher earnings, but lower revenue than Zuora. Zuora is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enfusion	$174.54M	6.68	$6.03M	$0.08	113.89
Zuora	$431.66M	3.15	-$68.19M	-$0.48	-19.40

Do institutionals & insiders have more ownership in ENFN or ZUO?

81.1% of Enfusion shares are owned by institutional investors. Comparatively, 83.0% of Zuora shares are owned by institutional investors. 39.2% of Enfusion shares are owned by company insiders. Comparatively, 9.3% of Zuora shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is ENFN or ZUO more profitable?

Enfusion has a net margin of 3.45% compared to Enfusion's net margin of -15.80%. Zuora's return on equity of 10.30% beat Enfusion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enfusion	3.45%	10.30%	7.78%
Zuora	-15.80%	-46.38%	-7.51%

Summary

Enfusion and Zuora tied by winning 9 of the 18 factors compared between the two stocks.